Cited 0 times in Scipus Cited Count

New occupational allergen in a pharmaceutical industry: serratial peptidase and lysozyme chloride.

DC Field Value Language
dc.contributor.authorPark, HS-
dc.contributor.authorNahm, DH-
dc.date.accessioned2011-09-07-
dc.date.available2011-09-07-
dc.date.issued1997-
dc.identifier.issn1081-1206-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/4053-
dc.description.abstractBACKGROUND: Serratial peptidase and lysozyme are often used as anti-inflammatory agents. There have been very few documented cases of occupational allergy caused by these substances. We report a case of a pharmaceutical industry worker who developed occupational asthma and rhinitis caused by both serratial peptidase and lysozyme chloride.



OBJECTIVE: It is important to alert physicians to the possibility of occupational asthma when dealing with workers in the pharmaceutical industry.



METHOD AND RESULT: The patient had strong positive responses to peptidase and lysozyme extracts on skin-prick tests. Bronchoprovocation tests showed a dual asthmatic response to peptidase and an early asthmatic response to lysozyme. Serum specific IgE antibodies to peptidase and lysozyme were detected by enzyme-linked immunosorbent assay (ELISA). In order to further characterize the allergenic component of these extracts, sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and electroblotting studies were also performed. More than ten components ranging form 7.3 to 83.1 kD were found in peptidase extracts, and two IgE binding components (67, 10.9 kD) were detected within the lysozyme extracts.



CONCLUSION: These findings suggest that inhalation of peptidase and lysozyme can induce IgE-mediated bronchoconstrictions in an exposed worker.
-
dc.language.isoen-
dc.subject.MESHAdult-
dc.subject.MESHAsthma-
dc.subject.MESHBronchial Provocation Tests-
dc.subject.MESHDrug Industry-
dc.subject.MESHElectrophoresis, Polyacrylamide Gel-
dc.subject.MESHEnzyme-Linked Immunosorbent Assay-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHImmunoblotting-
dc.subject.MESHImmunoglobulin E-
dc.subject.MESHMuramidase-
dc.subject.MESHOccupational Diseases-
dc.subject.MESHPeptide Hydrolases-
dc.subject.MESHRhinitis, Allergic, Perennial-
dc.subject.MESHSerratia-
dc.subject.MESHSkin Tests-
dc.titleNew occupational allergen in a pharmaceutical industry: serratial peptidase and lysozyme chloride.-
dc.typeArticle-
dc.identifier.pmid9048533-
dc.contributor.affiliatedAuthor박, 해심-
dc.contributor.affiliatedAuthor남, 동호-
dc.type.localJournal Papers-
dc.citation.titleAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology-
dc.citation.volume78-
dc.citation.number2-
dc.citation.date1997-
dc.citation.startPage225-
dc.citation.endPage229-
dc.identifier.bibliographicCitationAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 78(2). : 225-229, 1997-
dc.identifier.eissn1534-4436-
dc.relation.journalidJ010811206-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Allergy
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse